Literature DB >> 25380916

Bacterial and fungal infections in the early post-transplantation period after liver transplantation: etiologic agents and their susceptibility.

D Kawecki1, M Pacholczyk2, B Lagiewska2, A Sawicka-Grzelak3, M Durlik4, G Mlynarczyk3, A Chmura2.   

Abstract

OBJECTIVE: It has been reported in many studies that one of the main factors influencing morbidity and mortality in patients receiving transplants is infection after transplantation. PATIENTS AND METHODS: The study included 190 adult patients undergoing orthotopic liver transplantation (OLT) between September 2001 and December 2007. All the patients were followed prospectively for infections from the OLT date and during the first 4 weeks after surgery. Immunosuppression consisted of steroids and tacrolimus. Antimicrobial prophylaxis included piperacillin/tazobactam, fluconazole, and selective bowel decontamination (SBD) was performed. Samples of clinical materials were investigated for microbiological cultures. The micro-organisms were cultured and identified in accordance with standard bacteriological procedures. Susceptibility testing was performed using Clinical and Laboratory Standards Institute procedures.
RESULTS: From 190 OLT recipients, 2213 clinical samples were obtained for microbiological examination. Positive cultures were found in 27.2% (n = 603) of all samples tested; 1252 strains were collected. Gram-positive bacteria were found in 64.1% (n = 802), Gram-negative bacteria were found in 31.6% (n = 396), and fungal strains were isolated in 4.3% (n = 54). Surgical site specimens (n = 1031) were obtained from 190 recipients during the first month after transplantation. Positive cultures accounted for 29.2% (n = 301) of all samples tested. Among the isolated microbial strains (n = 677), most common were Gram-positive bacteria (73.7%; n = 499). Gram-negative bacteria comprised 25.1% (n = 170). There were fungal strains in 1.2% (n = 8). There were 539 urine specimens. Positive cultures accounted for 16.7% (n = 90) of those. Among the isolated microbial strains (n = 210), most common were Gram-negative bacteria (62.4%; n = 131). Gram-positive bacteria comprised 28.6% (n = 60) and fungi 9% (n = 19). There were 549 blood specimens. Positive cultures were found in 30.6% (n = 168) of all samples tested. Among the isolated microbial strains (n = 263), most common were Gram-positive bacteria in 72.3% (n = 190); Gram-negative bacteria were found in 26.2% (n = 69), and fungal strains were isolated in 1.5% (n = 4). There were 69 respiratory tract specimens. Positive cultures were found in 46.4% (n = 32) of all samples tested. Among the isolated microbial strains (n = 84), most common were Gram-positive bacteria (51.2%; n = 43); Gram-negative bacteria comprised 27.4% (n = 23) and fungi 21.4% (n = 18).
CONCLUSIONS: (1) Surgical site samples were predominated samples after LTx. (2) Our study showed Gram-positive bacteria were 64.1% (n = 802), Gram-negative bacteria, 31.6% (n = 396) and fungal strains isolated in 4.3% (n = 54). (3) The increased proportion of isolates of multi-drug-resistant bacterial strains (methicillin resistant coagulase negative Staphylococcus, vancomycin-resistant Enterococcus, high-level aminoglycoside resistance, and extended- spectrum β-lactamase). (4) These data indicate strict cooperation infection control procedures in these patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25380916     DOI: 10.1016/j.transproceed.2014.08.031

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  9 in total

Review 1.  Antimicrobial resistance: a global multifaceted phenomenon.

Authors:  Francesca Prestinaci; Patrizio Pezzotti; Annalisa Pantosti
Journal:  Pathog Glob Health       Date:  2015-09-07       Impact factor: 2.894

2.  Antibiotics-mediated intestinal microbiome perturbation aggravates tacrolimus-induced glucose disorders in mice.

Authors:  Yuqiu Han; Xiangyang Jiang; Qi Ling; Li Wu; Pin Wu; Ruiqi Tang; Xiaowei Xu; Meifang Yang; Lijiang Zhang; Weiwei Zhu; Baohong Wang; Lanjuan Li
Journal:  Front Med       Date:  2019-05-02       Impact factor: 4.592

3.  Carbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients.

Authors:  Francesco Barchiesi; Roberto Montalti; Pamela Castelli; Daniele Nicolini; Silvia Staffolani; Federico Mocchegiani; Alessandro Fiorentini; Esther Manso; Marco Vivarelli
Journal:  BMC Infect Dis       Date:  2016-10-04       Impact factor: 3.090

Review 4.  Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment.

Authors:  Jamie C DeWitt; Dori R Germolec; Robert W Luebke; Victor J Johnson
Journal:  Curr Protoc Toxicol       Date:  2016-02-01

5.  Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.

Authors:  Jia-Shuo Chao; Sen-Lin Zhao; Si-Wen Ou-Yang; Yong-Bing Qian; Ai-Qun Liu; Hua-Mei Tang; Lin Zhong; Zhi-Hai Peng; Jun-Ming Xu; Hong-Cheng Sun
Journal:  World J Gastroenterol       Date:  2019-10-07       Impact factor: 5.742

6.  Bacterial and Fungal Infections After Liver Transplantation: Microbial Epidemiology, Risk Factors for Infection and Death with Infection.

Authors:  Weili Zhang; Wentao Wang; Mei Kang; Siying Wu; Ya Liu; Quanfeng Liao; Yuling Xiao; Ying Ma; Yi Xie
Journal:  Ann Transplant       Date:  2020-05-19       Impact factor: 1.530

7.  In-hospital mortality of liver transplantation and risk factors: a single-center experience.

Authors:  Xing-Mao Zhang; Hua Fan; Qiao Wu; Xin-Xue Zhang; Ren Lang; Qiang He
Journal:  Ann Transl Med       Date:  2021-03

Review 8.  Selective Intestinal Decontamination as a Method for Preventing Infectious Complications (Review).

Authors:  A L Barsuk; E S Nekaeva; L V Lovtsova; A L Urakov
Journal:  Sovrem Tekhnologii Med       Date:  2020-12-28

9.  Drug Resistance and Risk Factors for Acquisition of Gram-Negative Bacteria and Carbapenem-Resistant Organisms Among Liver Transplant Recipients.

Authors:  Xiaoxia Wu; Guo Long; Weiting Peng; Qiquan Wan
Journal:  Infect Dis Ther       Date:  2022-05-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.